Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Annals of the New York Academy of Sciences
|
November 27, 2014
The osteoblastic niche in the context of multiple myeloma
Denise Toscani, Marina Bolzoni, Fabrizio Accardi, et al.
Calcified Tissue International
|
October 30, 2017
The Proteasome and Myeloma-Associated Bone Disease
Fabrizio Accardi, Denise Toscani, Federica Costa, et al.
Journal of Clinical Medicine
|
September 23, 2020
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
Benedetta Dalla Palma, Valentina Marchica, Maria Teresa Catarozzo, et al.
Biomed Research International
|
November 19, 2015
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Fabrizio Accardi, Denise Toscani, Marina Bolzoni, et al.
Expert Review of Hematology
|
May 25, 2019
Novel targets for the treatment of relapsing multiple myeloma
Nicola Giuliani, Fabrizio Accardi, Valentina Marchica, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 9, 2026
[Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits (PGNMID) Associated with Marginal Zone B-cell Lymphoma: A Case of MGRS in a Patient with Nephrotic Syndrome and Rapidly Progressive Renal Failure]
Luca Visconti, Sebastiano Calimeri, Guido Gembillo, et al.
Leukemia
|
July 22, 2021
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
Jooeun Bae, Fabrizio Accardi, Teru Hideshima, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 10, 2015
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors
Denise Toscani, Carla Palumbo, Benedetta Dalla Palma, et al.
Case Reports in Hematology
|
April 14, 2018
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis
Fabrizio Accardi, Valentina Papa, Anna Rita Capozzi, et al.
Hematology Reports
|
May 4, 2018
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Fabrizio Accardi, Valentina Marchica, Cristina Mancini, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Annals of the New York Academy of Sciences
|
November 27, 2014
The osteoblastic niche in the context of multiple myeloma
Denise Toscani, Marina Bolzoni, Fabrizio Accardi, et al.
Calcified Tissue International
|
October 30, 2017
The Proteasome and Myeloma-Associated Bone Disease
Fabrizio Accardi, Denise Toscani, Federica Costa, et al.
Journal of Clinical Medicine
|
September 23, 2020
Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
Benedetta Dalla Palma, Valentina Marchica, Maria Teresa Catarozzo, et al.
Biomed Research International
|
November 19, 2015
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling
Fabrizio Accardi, Denise Toscani, Marina Bolzoni, et al.
Expert Review of Hematology
|
May 25, 2019
Novel targets for the treatment of relapsing multiple myeloma
Nicola Giuliani, Fabrizio Accardi, Valentina Marchica, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
July 9, 2026
[Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits (PGNMID) Associated with Marginal Zone B-cell Lymphoma: A Case of MGRS in a Patient with Nephrotic Syndrome and Rapidly Progressive Renal Failure]
Luca Visconti, Sebastiano Calimeri, Guido Gembillo, et al.
Leukemia
|
July 22, 2021
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma
Jooeun Bae, Fabrizio Accardi, Teru Hideshima, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 10, 2015
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors
Denise Toscani, Carla Palumbo, Benedetta Dalla Palma, et al.
Case Reports in Hematology
|
April 14, 2018
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis
Fabrizio Accardi, Valentina Papa, Anna Rita Capozzi, et al.
Hematology Reports
|
May 4, 2018
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Fabrizio Accardi, Valentina Marchica, Cristina Mancini, et al.
Page
of 3